Related Experiment Video
Updated: Feb 28, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Treatment Decision-making and Weight Loss Expectations for Current Obesity Treatment
Sujaytha Paknikar1, Meera Shah2
1Mayo Clinic Division of Endocrinology 1, RO_MA_18_03E-EN Mayo Building 200 1st St SW, Rochester, MN, 55905, USA.
Current Obesity Reports
|February 27, 2026
Summary
Shared decision-making frameworks are crucial for obesity treatment. This review explores factors influencing patient and provider choices for effective obesity management, aiming for personalized care.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Obesity is a growing global health crisis, classified as a chronic medical condition.
- Current obesity treatments include lifestyle interventions, pharmacotherapy, and bariatric surgery.
- Emerging medical therapies show efficacy comparable to bariatric surgery, yet face challenges in utilization and selection.
Purpose of the Study:
- To establish a framework for shared decision-making in obesity treatment.
- To analyze factors influencing treatment choices for obesity.
- To guide individualized obesity management strategies.
Main Methods:
- This review synthesizes current literature on obesity treatment modalities.
- It examines patient and provider perspectives, alongside behavioral, biological, and socioeconomic determinants.
- The analysis focuses on optimizing treatment selection through shared decision-making.
Main Results:
- Incretin-based therapies offer significant efficacy in obesity management.
- Underutilization and suboptimal treatment selection remain key challenges.
- Patient/provider expectations and diverse patient factors critically impact treatment decisions.
Conclusions:
- A personalized approach to obesity treatment is essential.
- Shared decision-making can improve treatment adherence and outcomes.
- Future research should focus on genetic and phenotypic characterization for tailored obesity care.
Related Concept Videos
01:21Drug Dosing: Obese Patients
315
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
315
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:25Role of Communication in the Nursing Process II: Planning and Implementation
2.8K
Several factors are considered while creating a patient's care plan. Motivation is a factor in improving communication, and patients often require encouragement to try different approaches involving significant change. It is essential to involve the patient and family in decisions about the plan of care to determine whether the suggested methods are acceptable. Consider meeting critical comfort and safety needs before introducing new communication methods and techniques. Allow adequate time...
2.8K